{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:19:24Z","timestamp":1791001164465,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbadis.2019.06.012","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:24:24Z","timestamp":1560547464000},"page":"165498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses"],"prefix":"10.1016","volume":"1866","author":[{"given":"Rachel A.","family":"Kline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy E.","family":"Heywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.06.012_bb0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/524503a","article-title":"The DNA of a nation","volume":"524","author":"Marx","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005457","article-title":"Transcriptomics technologies","volume":"13","author":"Lowe","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0020","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1074\/mcp.RA118.000935","article-title":"Epigenetic variability confounds transcriptome but not proteome profiling for coexpression-based gene function prediction","volume":"17","author":"Grabowski","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature19947","article-title":"Proteome complexity and the forces that drive proteome imbalance","volume":"537","author":"Harper","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.201612010","article-title":"Why proteomics is not the new genomics and the future of mass spectrometry in cell biology","volume":"216","author":"Sidoli","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10545-017-0131-6","article-title":"Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients","volume":"41","author":"Coene","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0040","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","article-title":"NCL disease mechanisms","volume":"1832","author":"Palmer","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbadis.2017.04.003","article-title":"NCLs and ER: a stressful relationship","volume":"1863","author":"Marotta","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2660(01)45005-X","article-title":"Biochemistry of neuronal ceroid lipofuscinoses","volume":"45","author":"Junaid","year":"2001","journal-title":"Adv. Genet."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0060","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/pr301125k","article-title":"Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach","volume":"12","author":"Scifo","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jprot.2015.03.038","article-title":"Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells","volume":"123","author":"Scifo","year":"2015","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fncel.2019.00092","article-title":"The interactome of palmitoyl-protein thioesterase 1 (PPT1) affects neuronal morphology and function","volume":"13","author":"Sapir","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","article-title":"A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis","volume":"75","author":"Nishimura","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2009.12.024","article-title":"WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened","volume":"166","author":"Beirowski","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2019.06.012_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12017-015-8382-6","article-title":"Proteomic profiling in the brain of CLN1 disease model reveals affected functional modules","volume":"18","author":"Tikka","year":"2016","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cellsig.2017.11.001","article-title":"Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium","volume":"42","author":"Huber","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fnmol.2017.00266","article-title":"The networks of genes encoding palmitoylated proteins in axonal and synaptic compartments are affected in PPT1 overexpressing neuronal-like cells","volume":"10","author":"Pezzini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/hmg\/ddx074","article-title":"Proteomics insights into infantile neuronal ceroid lipofuscinosis (CLN1) point to the involvement of cilia pathology in the disease","volume":"26","author":"Segal-Salto","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12603-0","article-title":"Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo","volume":"7","author":"Llavero Hurtado","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00401-015-1512-2","article-title":"Neuronal ceroid lipofuscinosis with DNAJC5\/CSPalpha mutation has PPT1 pathology and exhibit aberrant protein palmitoylation","volume":"131","author":"Henderson","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2012.10.004","article-title":"Cathepsin D deficiency induces cytoskeletal changes and affects cell migration pathways in the brain","volume":"50","author":"Koch","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0130","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","article-title":"Lipidomic and transcriptomic basis of lysosomal dysfunction in progranulin deficiency","volume":"20","author":"Evers","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0135","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-75402-4_12","article-title":"Gene therapy approaches to treat the neurodegeneration and visual failure in neuronal ceroid lipofuscinoses","volume":"1074","author":"Kleine Holthaus","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/febs.13593","article-title":"Plasma biomarkers for neuronal ceroid lipofuscinosis","volume":"283","author":"Hersrud","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0150","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1021\/acs.jproteome.7b00460","article-title":"Proteomic analysis of brain and cerebrospinal fluid from the three major forms of neuronal ceroid lipofuscinosis reveals potential biomarkers","volume":"16","author":"Sleat","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33449-0","article-title":"Untargeted metabolite profiling of cerebrospinal fluid uncovers biomarkers for severity of late infantile neuronal ceroid lipofuscinosis (CLN2, Batten disease)","volume":"8","author":"Sindelar","year":"2018","journal-title":"Sci. Rep."},{"issue":"Suppl. 3","key":"10.1016\/j.bbadis.2019.06.012_bb0160","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1007\/s10545-010-9197-0","article-title":"Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter syndrome)","volume":"33","author":"Davison","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006680","article-title":"Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases","volume":"13","author":"Kline","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.nmd.2016.06.004","article-title":"Commonality amid diversity: multi-study proteomic identification of conserved disease mechanisms in spinal muscular atrophy","volume":"26","author":"Fuller","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8120212","article-title":"Multi-study proteomic and bioinformatic identification of molecular overlap between amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA)","volume":"8","author":"Soltic","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0921-8734(89)90010-6","article-title":"Increased sensitivity of various genes to endogenous DNase activity in terminal differentiating chick lens fibers","volume":"219","author":"Muel","year":"1989","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0185","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.celrep.2015.08.047","article-title":"Diminished MTORC1-dependent JNK activation underlies the neurodevelopmental defects associated with lysosomal dysfunction","volume":"12","author":"Wong","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0190","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","article-title":"Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stages of Parkinson disease","volume":"88","author":"Boutin","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0195","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12967-015-0424-1","article-title":"Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases","volume":"13","author":"Santacatterina","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2019.06.012_bb0205","first-page":"342","article-title":"Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1\/5 double-knockout mice","volume":"6","author":"Blom","year":"2013","journal-title":"Dis. Model. Mech."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391930211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544391930211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:54:52Z","timestamp":1760417692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544391930211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S092544391930211X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.012","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"165498"}}